TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs28642901
log Bayes Factor = 109.678
Chromosome 6   position 31,381,808  (GRCh37) Explore rs28642901 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
K90.0 Coeliac disease
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
1.000 0.000 0.000
L40.5 Arthropathic psoriasis
1.000 0.000 0.000
M45.X9 Ankylosing spondylitis (Site unspecified)
1.000 0.000 0.000
L40 Psoriasis
1.000 0.000 0.000
M07.3 Other psoriatic arthropathies
1.000 0.000 0.000
M07.30 Other psoriatic arthropathies (Multiple sites)
1.000 0.000 0.000
M45 Ankylosing spondylitis
1.000 0.000 0.000
M07.39 Other psoriatic arthropathies (Site unspecified)
0.999 0.001 0.000
M45.X0 Ankylosing spondylitis (Multiple sites in spine)
0.999 0.001 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.998 0.002 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.997 0.003 0.000
T43.2 Other and unspecified antidepressants
0.995 0.005 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.993 0.007 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.987 0.013 0.000
J45.9 Asthma, unspecified
0.000 0.016 0.984
L40.0 Psoriasis vulgaris
0.977 0.023 0.000
S01 Open wound of head
0.000 0.025 0.975
S00-S09 Injuries to the head
0.000 0.028 0.972
S02 Fracture of skull and facial bones
0.000 0.035 0.965
S01.3 Open wound of ear
0.000 0.043 0.957
J45 Asthma
0.000 0.043 0.957
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.957 0.043 0.000
T39.1 4-Aminophenol derivatives
0.955 0.045 0.000
S00 Superficial injury of head
0.000 0.046 0.954
S01.8 Open wound of other parts of head
0.000 0.051 0.949
M45.X2 Ankylosing spondylitis (Cervical region)
0.948 0.052 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.939 0.061 0.000
M07.37 Other psoriatic arthropathies (Ankle and foot)
0.937 0.063 0.000
J45.0 Predominantly allergic asthma
0.000 0.070 0.930
T42.4 Benzodiazepines
0.925 0.075 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.922 0.078 0.000
S02.4 Fracture of malar and maxillary bones
0.000 0.079 0.921
S00.1 Contusion of eyelid and periocular area
0.000 0.085 0.915
S02.8 Fractures of other skull and facial bones
0.000 0.094 0.906
S01.1 Open wound of eyelid and periocular area
0.000 0.103 0.897
S02.40 Fracture of malar and maxillary bones (closed)
0.000 0.110 0.890
M07.34 Other psoriatic arthropathies (Hand)
0.886 0.114 0.000
S06 Intracranial injury
0.000 0.114 0.886
M07.36 Other psoriatic arthropathies (Lower leg)
0.880 0.120 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.879 0.121 0.000
S01.7 Multiple open wounds of head
0.000 0.122 0.878
S00.3 Superficial injury of nose
0.000 0.128 0.872
S02.80 Fractures of other skull and facial bones (closed)
0.000 0.136 0.864
S02.6 Fracture of mandible
0.000 0.137 0.863
S00.2 Other superficial injuries of eyelid and periocular area
0.000 0.156 0.844
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)
0.836 0.164 0.000
L40.1 Generalised pustular psoriasis
0.829 0.171 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.828 0.172 0.000
L40.4 Guttate psoriasis
0.827 0.173 0.000
M45.X6 Ankylosing spondylitis (Lumbar region)
0.827 0.173 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.827 0.173 0.000
S01.4 Open wound of cheek and temporomandibular area
0.000 0.183 0.817
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.817 0.183 0.000
K90 Intestinal malabsorption
0.000 0.185 0.815
T43.5 Other and unspecified antipsychotics and neuroleptics
0.814 0.186 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.800 0.200 0.000
L40.8 Other psoriasis
0.799 0.201 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.797 0.203 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.793 0.206 0.000
S00.7 Multiple superficial injuries of head
0.000 0.207 0.793
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.791 0.209 0.000
S02.60 Fracture of mandible (closed)
0.000 0.209 0.791
M07.31 Other psoriatic arthropathies (Shoulder region)
0.790 0.210 0.000
S06.2 Diffuse brain injury
0.000 0.213 0.787
T38.1 Thyroid hormones and substitutes
0.783 0.217 0.000
T39.0 Salicylates
0.779 0.221 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.775 0.225 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.773 0.227 0.000
T42.1 Iminostilbenes
0.772 0.228 0.000
J33.0 Polyp of nasal cavity
0.000 0.228 0.772
J33 Nasal polyp
0.000 0.233 0.767
S00.5 Superficial injury of lip and oral cavity
0.000 0.233 0.767
S02.9 Fracture of skull and facial bones, part unspecified
0.000 0.233 0.766
T42.0 Hydantoin derivatives
0.765 0.235 0.000
J40-J47 Chronic lower respiratory diseases
0.000 0.238 0.762
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.762 0.238 0.000
S01.5 Open wound of lip and oral cavity
0.000 0.239 0.761
T50.8 Diagnostic agents
0.756 0.244 0.000
S06.3 Focal brain injury
0.000 0.245 0.755
Chapter X Diseases of the respiratory system
0.000 0.246 0.754
J80-J84 Other respiratory diseases principally affecting the interstitium
0.000 0.253 0.747
J84 Other interstitial pulmonary diseases
0.000 0.254 0.746
J30-J39 Other diseases of upper respiratory tract
0.000 0.254 0.746
K90.9 Intestinal malabsorption, unspecified
0.000 0.259 0.741
S02.7 Multiple fractures involving skull and facial bones
0.000 0.261 0.739
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.738 0.262 0.000
J30 Vasomotor and allergic rhinitis
0.000 0.264 0.736
J30.1 Allergic rhinitis due to pollen
0.000 0.272 0.728
J84.1 Other interstitial pulmonary diseases with fibrosis
0.000 0.276 0.724
L40.3 Pustulosis palmaris et plantaris
0.717 0.283 0.000
L40.2 Acrodermatitis continua
0.717 0.283 0.000
M07.38 Other psoriatic arthropathies (Other)
0.717 0.283 0.000
M07.33 Other psoriatic arthropathies (Forearm)
0.717 0.283 0.000
M07.32 Other psoriatic arthropathies (Upper arm)
0.717 0.283 0.000
M45.X8 Ankylosing spondylitis (Sacral and sacrococcygeal region)
0.717 0.283 0.000
M45.X7 Ankylosing spondylitis (Lumbosacral region)
0.717 0.283 0.000
M45.X5 Ankylosing spondylitis (Thoracolumbar region)
0.717 0.283 0.000
M45.X4 Ankylosing spondylitis (Thoracic region)
0.717 0.283 0.000
M45.X3 Ankylosing spondylitis (Cervicothoracic region)
0.717 0.283 0.000
M45.X1 Ankylosing spondylitis (Occipito-atlanto-axial region)
0.717 0.283 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.716 0.284 0.000
S06.20 Diffuse brain injury (without open intracranial wound)
0.000 0.284 0.716
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.715 0.285 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.715 0.285 0.000
T43.9 Psychotropic drug, unspecified
0.715 0.285 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.715 0.285 0.000
T43.6 Psychostimulants with abuse potential
0.714 0.286 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.712 0.288 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.712 0.288 0.000
T42.3 Barbiturates
0.712 0.288 0.000
T42.2 Succinimides and oxazolidinediones
0.712 0.288 0.000
S06.6 Traumatic subarachnoid haemorrhage
0.000 0.289 0.711
T39.4 Antirheumatics, not elsewhere classified
0.708 0.292 0.000
T39.2 Pyrazolone derivatives
0.708 0.292 0.000
J84.9 Interstitial pulmonary disease, unspecified
0.000 0.297 0.703
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.700 0.300 0.000
S02.2 Fracture of nasal bones
0.000 0.300 0.700
S08 Traumatic amputation of part of head
0.000 0.303 0.697
S07 Crushing injury of head
0.000 0.303 0.697
S04 Injury of cranial nerves
0.000 0.303 0.697
J33.9 Nasal polyp, unspecified
0.000 0.304 0.696
S00.0 Superficial injury of scalp
0.000 0.304 0.696
K90.8 Other intestinal malabsorption
0.000 0.305 0.695
T50.6 Antidotes and chelating agents, not elsewhere classified
0.694 0.306 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.694 0.306 0.000
S03 Dislocation, sprain and strain of joints and ligaments of head
0.000 0.313 0.687
J45.8 Mixed asthma
0.000 0.314 0.686
J45.1 Nonallergic asthma
0.000 0.314 0.686
J95-J99 Other diseases of the respiratory system
0.000 0.314 0.686
S06.9 Intracranial injury, unspecified
0.000 0.314 0.686
S01.2 Open wound of nose
0.000 0.315 0.685
J99 Respiratory disorders in diseases classified elsewhere
0.000 0.324 0.675
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.674 0.326 0.000
T50.7 Analeptics and opioid receptor antagonists
0.673 0.326 0.000
T50.5 Appetite depressants
0.673 0.326 0.000
T50.4 Drugs affecting uric acid metabolism
0.673 0.326 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.673 0.326 0.000
T50.1 Loop [high-ceiling] diuretics
0.673 0.326 0.000
T50.0 Mineralocorticoids and their antagonists
0.673 0.326 0.000
J99.8 Respiratory disorders in other diseases classified elsewhere
0.000 0.328 0.672
T36 Poisoning by systemic antibiotics
0.670 0.330 0.000
S06.30 Focal brain injury (without open intracranial wound)
0.000 0.338 0.661
T38.9 Other and unspecified hormone antagonists
0.661 0.339 0.000
T38.7 Androgens and anabolic congeners
0.661 0.339 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.661 0.339 0.000
T38.5 Other oestrogens and progestogens
0.661 0.339 0.000
T38.4 Oral contraceptives
0.661 0.339 0.000
T38.2 Antithyroid drugs
0.661 0.339 0.000
T38.0 Glucocorticoids and synthetic analogues
0.661 0.339 0.000
S02.41 Fracture of malar and maxillary bones (open)
0.000 0.339 0.660
S02.5 Fracture of tooth
0.000 0.342 0.657
S02.81 Fractures of other skull and facial bones (open)
0.000 0.350 0.650
N47 Redundant prepuce, phimosis and paraphimosis
0.000 0.351 0.649
T48.6 Antiasthmatics, not elsewhere classified
0.647 0.353 0.000
S02.0 Fracture of vault of skull
0.000 0.356 0.643
L40-L45 Papulosquamous disorders
0.641 0.359 0.000
S06.7 Intracranial injury with prolonged coma
0.000 0.365 0.635
S06.1 Traumatic cerebral oedema
0.000 0.365 0.635
S06.4 Epidural haemorrhage
0.000 0.372 0.628
S02.90 Fracture of skull and facial bones, part unspecified (closed)
0.000 0.375 0.625
J46 Status asthmaticus
0.000 0.377 0.622
J84.8 Other specified interstitial pulmonary diseases
0.000 0.379 0.621
S00.4 Superficial injury of ear
0.000 0.380 0.620
J30.3 Other allergic rhinitis
0.000 0.380 0.620
S02.61 Fracture of mandible (open)
0.000 0.381 0.619
J33.8 Other polyp of sinus
0.000 0.385 0.615
J85-J86 Suppurative and necrotic conditions of lower respiratory tract
0.000 0.386 0.614
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.608 0.392 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.606 0.394 0.000
S06.5 Traumatic subdural haemorrhage
0.000 0.396 0.604
J30.0 Vasomotor rhinitis
0.000 0.399 0.601
S02.1 Fracture of base of skull
0.000 0.400 0.600
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.594 0.406 0.000
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)
0.000 0.414 0.586
K90.3 Pancreatic steatorrhoea
0.000 0.416 0.584
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.416 0.584
K90.1 Tropical sprue
0.000 0.416 0.584
J33.1 Polypoid sinus degeneration
0.000 0.422 0.578
S02.70 Multiple fractures involving skull and facial bones (closed)
0.000 0.423 0.577
S06.8 Other intracranial injuries
0.000 0.423 0.577
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.426 0.574
T46.1 Calcium-channel blockers
0.572 0.428 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.569 0.431 0.000
T48.5 Anti-common-cold drugs
0.569 0.431 0.000
T48.4 Expectorants
0.569 0.431 0.000
T48.3 Antitussives
0.569 0.431 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.569 0.431 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.569 0.431 0.000
T48.0 Oxytocic drugs
0.569 0.431 0.000
L42 Pityriasis rosea
0.566 0.434 0.000
S06.21 Diffuse brain injury (with open intracranial wound)
0.000 0.436 0.564
T47.0 Histamine H(2)-receptor antagonists
0.563 0.437 0.000
S05 Injury of eye and orbit
0.000 0.447 0.553
S02.91 Fracture of skull and facial bones, part unspecified (open)
0.000 0.450 0.550
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.546 0.454 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.546 0.454 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.546 0.454 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.546 0.454 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.546 0.454 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.546 0.454 0.000
T44.0 Anticholinesterase agents
0.546 0.454 0.000
S06.90 Intracranial injury, unspecified (without open intracranial wound)
0.000 0.457 0.543
J41 Simple and mucopurulent chronic bronchitis
0.000 0.458 0.541
S06.31 Focal brain injury (with open intracranial wound)
0.000 0.459 0.541
J84.0 Alveolar and parietoalveolar conditions
0.000 0.465 0.535
J90-J94 Other diseases of pleura
0.000 0.470 0.530
S02.71 Multiple fractures involving skull and facial bones (open)
0.000 0.470 0.530
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.529 0.470 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.529 0.470 0.000
T47.7 Emetics
0.529 0.470 0.000
T47.6 Antidiarrhoeal drugs
0.529 0.470 0.000
T47.5 Digestants
0.529 0.470 0.000
T47.4 Other laxatives
0.529 0.470 0.000
T47.3 Saline and osmotic laxatives
0.529 0.470 0.000
T47.2 Stimulant laxatives
0.529 0.470 0.000
S02.20 Fracture of nasal bones (closed)
0.000 0.472 0.528
S02.3 Fracture of orbital floor
0.000 0.477 0.522
J82 Pulmonary eosinophilia, not elsewhere classified
0.000 0.480 0.520
T47.1 Other antacids and anti-gastric-secretion drugs
0.516 0.483 0.000
T41.5 Therapeutic gases
0.513 0.487 0.000
T41.4 Anaesthetic, unspecified
0.513 0.487 0.000
T41.3 Local anaesthetics
0.513 0.487 0.000
T41.2 Other and unspecified general anaesthetics
0.513 0.487 0.000
T41.1 Intravenous anaesthetics
0.513 0.487 0.000
T41.0 Inhaled anaesthetics
0.513 0.487 0.000
T49.9 Topical agent, unspecified
0.513 0.487 0.000
T49.8 Other topical agents
0.513 0.487 0.000
T49.7 Dental drugs, topically applied
0.513 0.487 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.513 0.487 0.000
T49.5 Ophthalmological drugs and preparations
0.513 0.487 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.513 0.487 0.000
T49.3 Emollients, demulcents and protectants
0.513 0.487 0.000
T49.2 Local astringents and local detergents
0.513 0.487 0.000
T49.1 Antipruritics
0.513 0.487 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.513 0.487 0.000
J80 Adult respiratory distress syndrome
0.000 0.489 0.511
S06.61 Traumatic subarachnoid haemorrhage (with open intracranial wound)
0.000 0.490 0.510
S06.0 Concussion
0.000 0.495 0.504
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.502 0.498 0.000
T37.5 Antiviral drugs
0.502 0.498 0.000
T37.4 Anthelminthics
0.502 0.498 0.000
T37.3 Other antiprotozoal drugs
0.502 0.498 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.502 0.498 0.000
T37.1 Antimycobacterial drugs
0.502 0.498 0.000
T37.0 Sulphonamides
0.502 0.498 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.502 0.498 0.000
S04.9 Injury of unspecified cranial nerve
0.000 0.500 0.500
S04.8 Injury of other cranial nerves
0.000 0.500 0.500
S04.7 Injury of accessory nerve
0.000 0.500 0.500
S04.6 Injury of acoustic nerve
0.000 0.500 0.500
S04.5 Injury of facial nerve
0.000 0.500 0.500
S04.4 Injury of abducent nerve
0.000 0.500 0.500
S04.3 Injury of trigeminal nerve
0.000 0.500 0.500
S04.2 Injury of trochlear nerve
0.000 0.500 0.500
S04.1 Injury of oculomotor nerve
0.000 0.500 0.500
S04.0 Injury of optic nerve and pathways
0.000 0.500 0.500
S07.9 Crushing injury of head, part unspecified
0.000 0.500 0.500
S07.8 Crushing injury of other parts of head
0.000 0.500 0.500
S07.1 Crushing injury of skull
0.000 0.500 0.500
S07.0 Crushing injury of face
0.000 0.500 0.500
S08.9 Traumatic amputation of unspecified part of head
0.000 0.500 0.500
S08.8 Traumatic amputation of other parts of head
0.000 0.500 0.500
S08.1 Traumatic amputation of ear
0.000 0.500 0.500
S08.0 Avulsion of scalp
0.000 0.500 0.500
J37 Chronic laryngitis and laryngotracheitis
0.000 0.502 0.498
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.497 0.502 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.497 0.503 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.497 0.503 0.000
T46.7 Peripheral vasodilators
0.497 0.503 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.497 0.503 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.497 0.503 0.000
S03.5 Sprain and strain of joints and ligaments of other and unspecified parts of head
0.000 0.507 0.492
S03.4 Sprain and strain of jaw
0.000 0.507 0.492
S03.3 Dislocation of other and unspecified parts of head
0.000 0.507 0.492
S03.1 Dislocation of septal cartilage of nose
0.000 0.507 0.492
S03.0 Dislocation of jaw
0.000 0.507 0.492
J93 Pneumothorax
0.000 0.508 0.492
S06.91 Intracranial injury, unspecified (with open intracranial wound)
0.000 0.508 0.492
J96 Respiratory failure, not elsewhere classified
0.000 0.508 0.492
J36 Peritonsillar abscess
0.000 0.508 0.491
T37.8 Other specified systemic anti-infectives and antiparasitics
0.487 0.513 0.000
J86 Pyothorax
0.000 0.517 0.483
S03.2 Dislocation of tooth
0.000 0.518 0.482
S01.9 Open wound of head, part unspecified
0.000 0.518 0.482
M07 Psoriatic and enteropathic arthropathies
0.481 0.519 0.000
S02.21 Fracture of nasal bones (open)
0.000 0.519 0.481
J85 Abscess of lung and mediastinum
0.000 0.519 0.481
T36.9 Systemic antibiotic, unspecified
0.480 0.519 0.000
T36.8 Other systemic antibiotics
0.480 0.519 0.000
T36.7 Antifungal antibiotics, systemically used
0.480 0.519 0.000
T36.6 Rifamycins
0.480 0.519 0.000
T36.5 Aminoglycosides
0.480 0.519 0.000
T36.4 Tetracyclines
0.480 0.519 0.000
T36.3 Macrolides
0.480 0.519 0.000
T36.2 Chloramphenicol group
0.480 0.519 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.480 0.519 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.473 0.527 0.000
S02.51 Fracture of tooth (open)
0.000 0.528 0.471
J30.2 Other seasonal allergic rhinitis
0.000 0.533 0.467
J91 Pleural effusion in conditions classified elsewhere
0.000 0.534 0.466
L43 Lichen planus
0.465 0.535 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.464 0.536 0.000
T40.1 Heroin
0.463 0.537 0.000
J81 Pulmonary oedema
0.000 0.537 0.463
S02.01 Fracture of vault of skull (open)
0.000 0.538 0.461
L44 Other papulosquamous disorders
0.460 0.540 0.000
L41 Parapsoriasis
0.460 0.540 0.000
L45 Papulosquamous disorders in diseases classified elsewhere
0.460 0.540 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.458 0.542 0.000
S06.11 Traumatic cerebral oedema (with open intracranial wound)
0.000 0.545 0.455
S06.10 Traumatic cerebral oedema (without open intracranial wound)
0.000 0.545 0.455
S06.71 Intracranial injury with prolonged coma (with open intracranial wound)
0.000 0.545 0.455
S06.70 Intracranial injury with prolonged coma (without open intracranial wound)
0.000 0.545 0.455
S06.41 Epidural haemorrhage (with open intracranial wound)
0.000 0.549 0.450
J99.1 Respiratory disorders in other diffuse connective tissue disorders
0.000 0.554 0.446
J39 Other diseases of upper respiratory tract
0.000 0.555 0.445
S06.40 Epidural haemorrhage (without open intracranial wound)
0.000 0.556 0.443
J93.9 Pneumothorax, unspecified
0.000 0.557 0.443
S02.50 Fracture of tooth (closed)
0.000 0.562 0.437
T36.0 Penicillins
0.435 0.565 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.434 0.565 0.000
T40.8 Lysergide [LSD]
0.434 0.565 0.000
T40.7 Cannabis (derivatives)
0.434 0.565 0.000
T40.5 Cocaine
0.434 0.565 0.000
T40.3 Methadone
0.434 0.565 0.000
T40.0 Opium
0.434 0.565 0.000
S06.51 Traumatic subdural haemorrhage (with open intracranial wound)
0.000 0.567 0.433
J99.0 Rheumatoid lung disease
0.000 0.569 0.431
J86.0 Pyothorax with fistula
0.000 0.571 0.429
T46.4 Angiotensin-converting-enzyme inhibitors
0.426 0.574 0.000
J43 Emphysema
0.000 0.575 0.425
S05.9 Injury of eye and orbit, part unspecified
0.000 0.575 0.425
S05.0 Injury of conjunctiva and corneal abrasion without mention of foreign body
0.000 0.581 0.419
S05.8 Other injuries of eye and orbit
0.000 0.584 0.416
S02.11 Fracture of base of skull (open)
0.000 0.585 0.415
S06.81 Other intracranial injuries (with open intracranial wound)
0.000 0.586 0.414
S02.00 Fracture of vault of skull (closed)
0.000 0.586 0.413
T40.2 Other opioids
0.411 0.589 0.000
J47 Bronchiectasis
0.000 0.591 0.409
J93.1 Other spontaneous pneumothorax
0.000 0.598 0.402
T40.6 Other and unspecified narcotics
0.402 0.598 0.000
S06.50 Traumatic subdural haemorrhage (without open intracranial wound)
0.000 0.599 0.401
S05.7 Avulsion of eye
0.000 0.603 0.397
S05.6 Penetrating wound of eyeball without foreign body
0.000 0.603 0.397
S05.4 Penetrating wound of orbit with or without foreign body
0.000 0.603 0.397
S05.5 Penetrating wound of eyeball with foreign body
0.000 0.606 0.394
J41.8 Mixed simple and mucopurulent chronic bronchitis
0.000 0.612 0.388
J41.1 Mucopurulent chronic bronchitis
0.000 0.612 0.388
J00-J06 Acute upper respiratory infections
0.000 0.612 0.388
J44 Other chronic obstructive pulmonary disease
0.000 0.612 0.388
S01.0 Open wound of scalp
0.000 0.615 0.384
J41.0 Simple chronic bronchitis
0.000 0.617 0.383
T45.0 Antiallergic and antiemetic drugs
0.380 0.620 0.000
J85.1 Abscess of lung with pneumonia
0.000 0.622 0.378
L43.8 Other lichen planus
0.377 0.623 0.000
S02.31 Fracture of orbital floor (open)
0.000 0.625 0.375
J85.2 Abscess of lung without pneumonia
0.000 0.628 0.372
J39.2 Other diseases of pharynx
0.000 0.630 0.370
S05.3 Ocular laceration without prolapse or loss of intraocular tissue
0.000 0.632 0.368
J93.8 Other pneumothorax
0.000 0.634 0.366
J03 Acute tonsillitis
0.000 0.635 0.365
S06.01 Concussion (with open intracranial wound)
0.000 0.638 0.362
T43.0 Tricyclic and tetracyclic antidepressants
0.362 0.638 0.000
J93.0 Spontaneous tension pneumothorax
0.000 0.639 0.361
S02.10 Fracture of base of skull (closed)
0.000 0.640 0.360
T45.9 Primarily systemic and haematological agent, unspecified
0.360 0.640 0.000
T45.8 Other primarily systemic and haematological agents
0.360 0.640 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.360 0.640 0.000
T45.6 Fibrinolysis-affecting drugs
0.360 0.640 0.000
T45.4 Iron and its compounds
0.360 0.640 0.000
T45.3 Enzymes, not elsewhere classified
0.360 0.640 0.000
T40.4 Other synthetic narcotics
0.358 0.642 0.000
J37.1 Chronic laryngotracheitis
0.000 0.642 0.357
S06.80 Other intracranial injuries (without open intracranial wound)
0.000 0.644 0.355
J20-J22 Other acute lower respiratory infections
0.000 0.645 0.355
J96.9 Respiratory failure, unspecified
0.000 0.647 0.353
J96.1 Chronic respiratory failure
0.000 0.647 0.353
J96.0 Acute respiratory failure
0.000 0.647 0.353
T45.2 Vitamins, not elsewhere classified
0.352 0.647 0.000
J30.4 Allergic rhinitis, unspecified
0.000 0.651 0.349
J03.9 Acute tonsillitis, unspecified
0.000 0.652 0.348
J98 Other respiratory disorders
0.000 0.652 0.348
F30-F39 Mood [affective] disorders
0.346 0.654 0.000
M07.6 Other enteropathic arthropathies
0.345 0.655 0.000
M07.5 Arthropathy in ulcerative colitis
0.345 0.655 0.000
M07.4 Arthropathy in Crohn's disease [regional enteritis]
0.345 0.655 0.000
M07.2 Psoriatic spondylitis
0.345 0.655 0.000
M07.1 Arthritis mutilans
0.345 0.655 0.000
M07.0 Distal interphalangeal psoriatic arthropathy
0.345 0.655 0.000
J85.3 Abscess of mediastinum
0.000 0.655 0.345
F30 Manic episode
0.342 0.658 0.000
J44.8 Other specified chronic obstructive pulmonary disease
0.000 0.658 0.342
F31 Bipolar affective disorder
0.336 0.664 0.000
L43.3 Subacute (active) lichen planus
0.333 0.666 0.000
L43.2 Lichenoid drug reaction
0.333 0.666 0.000
L43.1 Bullous lichen planus
0.333 0.666 0.000
L43.0 Hypertrophic lichen planus
0.333 0.666 0.000
J94 Other pleural conditions
0.000 0.670 0.330
L41.9 Parapsoriasis, unspecified
0.330 0.670 0.000
L41.8 Other parapsoriasis
0.330 0.670 0.000
L41.5 Retiform parapsoriasis
0.330 0.670 0.000
L41.4 Large plaque parapsoriasis
0.330 0.670 0.000
L41.3 Small plaque parapsoriasis
0.330 0.670 0.000
L41.2 Lymphomatoid papulosis
0.330 0.670 0.000
L41.1 Pityriasis lichenoides chronica
0.330 0.670 0.000
L41.0 Pityriasis lichenoides et varioliformis acuta
0.330 0.670 0.000
L44.9 Papulosquamous disorder, unspecified
0.330 0.670 0.000
L44.8 Other specified papulosquamous disorders
0.330 0.670 0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.330 0.670 0.000
L44.3 Lichen ruber moniliformis
0.330 0.670 0.000
L44.2 Lichen striatus
0.330 0.670 0.000
L44.1 Lichen nitidus
0.330 0.670 0.000
L44.0 Pityriasis rubra pilaris
0.330 0.670 0.000
J42 Unspecified chronic bronchitis
0.000 0.671 0.329
F33 Recurrent depressive disorder
0.325 0.675 0.000
J85.0 Gangrene and necrosis of lung
0.000 0.676 0.323
J43.2 Centrilobular emphysema
0.000 0.677 0.322
S09 Other and unspecified injuries of head
0.000 0.679 0.321
J37.0 Chronic laryngitis
0.000 0.679 0.321
F30.9 Manic episode, unspecified
0.321 0.679 0.000
S05.2 Ocular laceration and rupture with prolapse or loss of intraocular tissue
0.000 0.680 0.320
J39.3 Upper respiratory tract hypersensitivity reaction, site unspecified
0.000 0.681 0.319
J39.1 Other abscess of pharynx
0.000 0.681 0.319
J60-J70 Lung diseases due to external agents
0.000 0.683 0.317
J35 Chronic diseases of tonsils and adenoids
0.000 0.687 0.313
S00.8 Superficial injury of other parts of head
0.000 0.693 0.307
F30.0 Hypomania
0.307 0.693 0.000
F33.1 Recurrent depressive disorder, current episode moderate
0.305 0.695 0.000
J43.1 Panlobular emphysema
0.000 0.695 0.305
J43.0 MacLeod's syndrome
0.000 0.695 0.305
S00.9 Superficial injury of head, part unspecified
0.000 0.698 0.302
J43.8 Other emphysema
0.000 0.700 0.300
F31.0 Bipolar affective disorder, current episode hypomanic
0.300 0.700 0.000
J98.6 Disorders of diaphragm
0.000 0.701 0.299
J31 Chronic rhinitis, nasopharyngitis and pharyngitis
0.001 0.703 0.296
J39.0 Retropharyngeal and parapharyngeal abscess
0.000 0.706 0.294
J98.0 Diseases of bronchus, not elsewhere classified
0.000 0.707 0.293
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms
0.292 0.708 0.000
F30.2 Mania with psychotic symptoms
0.285 0.715 0.000
F34 Persistent mood [affective] disorders
0.285 0.715 0.000
S05.1 Contusion of eyeball and orbital tissues
0.000 0.716 0.284
F31.3 Bipolar affective disorder, current episode mild or moderate depression
0.280 0.720 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.278 0.722 0.001
L43.9 Lichen planus, unspecified
0.275 0.725 0.000
F33.8 Other recurrent depressive disorders
0.272 0.728 0.000
F39 Unspecified mood [affective] disorder
0.272 0.728 0.000
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified
0.000 0.728 0.272
F60 Specific personality disorders
0.271 0.729 0.000
J05 Acute obstructive laryngitis [croup] and epiglottitis
0.000 0.729 0.271
J98.8 Other specified respiratory disorders
0.000 0.729 0.271
F60-F69 Disorders of adult personality and behaviour
0.269 0.731 0.000
J20 Acute bronchitis
0.000 0.734 0.266
Chapter V Mental and behavioural disorders
0.265 0.735 0.000
J39.9 Disease of upper respiratory tract, unspecified
0.000 0.736 0.264
J03.8 Acute tonsillitis due to other specified organisms
0.000 0.738 0.262
J03.0 Streptococcal tonsillitis
0.000 0.738 0.262
F31.8 Other bipolar affective disorders
0.261 0.739 0.000
F31.9 Bipolar affective disorder, unspecified
0.261 0.739 0.000
F60.3 Emotionally unstable personality disorder
0.259 0.741 0.000
F30.1 Mania without psychotic symptoms
0.257 0.743 0.000
J04 Acute laryngitis and tracheitis
0.000 0.744 0.256
J21 Acute bronchiolitis
0.000 0.745 0.255
J94.8 Other specified pleural conditions
0.000 0.747 0.253
J96.09 Acute respiratory failure; Type unspecified
0.000 0.747 0.253
J96.01 Acute respiratory failure; Type II [hypercapnic]
0.000 0.747 0.253
J96.00 Acute respiratory failure; Type I [hypoxic]
0.000 0.747 0.253
J96.19 Chronic respiratory failure; Type unspecified
0.000 0.747 0.253
J96.11 Chronic respiratory failure; Type II [hypercapnic]
0.000 0.747 0.253
J96.10 Chronic respiratory failure; Type I [hypoxic]
0.000 0.747 0.253
J96.99 Respiratory failure, unspecified; Type unspecified
0.000 0.747 0.253
J96.91 Respiratory failure unspecified; Type II [hypercapnic]
0.000 0.747 0.253
J96.90 Respiratory failure, unspecified; Type I [hypoxic]
0.000 0.747 0.253
T45.5 Anticoagulants
0.252 0.747 0.001
J02 Acute pharyngitis
0.000 0.747 0.253
F33.4 Recurrent depressive disorder, currently in remission
0.252 0.747 0.000
J67 Hypersensitivity pneumonitis due to organic dust
0.000 0.749 0.251
F33.9 Recurrent depressive disorder, unspecified
0.250 0.750 0.000
J98.3 Compensatory emphysema
0.000 0.750 0.249
F38 Other mood [affective] disorders
0.248 0.751 0.000
F60.9 Personality disorder, unspecified
0.248 0.752 0.000
M07.09 Distal interphalangeal psoriatic arthropathy (Site unspecified)
0.248 0.752 0.000
M07.08 Distal interphalangeal proriatic arthropathy-Other
0.248 0.752 0.000
M07.07 Distal interphalangeal psoriatic arthropathy (Ankle and foot)
0.248 0.752 0.000
M07.06 Distal interphalangeal proriatic arthropathy-Lower leg
0.248 0.752 0.000
M07.05 Distal interphalangeal proriatic arthropathy-Pelvic/thigh
0.248 0.752 0.000
M07.04 Distal interphalangeal psoriatic arthropathy (Hand)
0.248 0.752 0.000
M07.03 Distal interphalangeal proriatic arthropathy-Forearm
0.248 0.752 0.000
M07.02 Distal interphalangeal proriatic arthropathy-Upper arm
0.248 0.752 0.000
M07.01 Distal interphalangeal proriatic arthropathy-Shldr region
0.248 0.752 0.000
M07.00 Distal interphalangeal psoriatic arthropathy (Multiple sites)
0.248 0.752 0.000
M07.19 Arthritis mutilans (Site unspecified)
0.248 0.752 0.000
M07.18 Arthritis mutilans (Other)
0.248 0.752 0.000
M07.17 Arthritis mutilans (Ankle and foot)
0.248 0.752 0.000
M07.16 Arthritis mutilans (Lower leg)
0.248 0.752 0.000
M07.15 Arthritis mutilans (Pelvic region and thigh)
0.248 0.752 0.000
M07.14 Arthritis mutilans (Hand)
0.248 0.752 0.000
M07.13 Arthritis mutilans (Forearm)
0.248 0.752 0.000
M07.12 Arthritis mutilans (Upper arm)
0.248 0.752 0.000
M07.11 Arthritis mutilans (Shoulder region)
0.248 0.752 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.